Zynerba Pharmaceuticals, Inc.
ZYNEDelisted Oct 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621443
Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.
Holders of 5% or more of ZYNE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Zynerba Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Zynerba Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Zynerba Pharmaceuticals, Inc., newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | Rapp Michael | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Zynerba Pharmaceuticals, Inc. shares.
No Form 144 notices for Zynerba Pharmaceuticals, Inc. are on file.